Skip to main content
Log in

Alendronic acid

Osteosclerosis: 10 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Hutchinson M, O'Ryan F, Chavez V, Lathon PV, Sanchez G, Hatcher DC, Indresano AT, Lo JC.Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. Journal of Oral and Maxillofacial Surgery 68: 2232-2240, No. 9, Sep 2010. Available from: URL: http://dx.doi.org/10.1016/j.joms.2010.05.003 - USA

Download references

Additional information

Key words

Osteosclerosis; Alendronic-acid; adverse reactions; Elderly; drug-induced

An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alendronic acid. React. Wkly. 1426, 7 (2012). https://doi.org/10.2165/00128415-201214260-00021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00021

Keywords

Navigation